Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
Discussion
The PREOPANC trial is designed to investigate whether preoperative radiochemotherapy improves overall survival by means of increased (R0) resection rates in patients with resectable or borderline resectable pancreatic cancer.
Trial registration
Trial open for accrual: 3 April 2013
The Netherlands National Trial Register – NTR3709 (8 November 2012)
EU Clinical Trials Register – 2012-003181-40 (11 December 2012)
Source: Trials - Category: Research Source Type: clinical trials
More News: Borderline Tumor | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | CT Scan | Hospitals | Laparoscopy | Laparotomy | Pancreas | Pancreatic Cancer | PET Scan | Research | Study | Toxicology